ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
214 hedge funds and large institutions have $4.84B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 97 increasing their positions, 60 reducing their positions, and 39 closing their positions.
84% more call options, than puts
Call options by funds: $127M | Put options by funds: $68.9M
62% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 60
8% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 39
3% more capital invested
Capital invested by funds: $4.72B → $4.84B (+$126M)
0% more funds holding
Funds holding: 213 → 214 (+1)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$299M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$110M |
| 3 |
KCM
Kingdon Capital Management
New York
|
+$46M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$44.8M |
| 5 |
Goldman Sachs
New York
|
+$30.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$114M |
| 2 |
Millennium Management
New York
|
-$114M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$43.2M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$40M |
| 5 |
Renaissance Technologies
New York
|
-$36.5M |
ANAC Hedge Fund Activity: Q4 2015 in Review
214 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q4 2015, worth a combined $4.84B — up 2.7% from $4.72B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new ANAC positions and 39 closed out — a net gain of 3 holders — while 97 added to existing stakes and 60 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $299M. The largest seller was VHCP Management, cutting an estimated $114M.
- 214 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q4 2015, up from 213 in Q3 2015.
- Funds reported $4.84B of ANACOR PHARMACEUTICALS INC COM stock for Q4 2015, up 2.7% quarter-over-quarter.
- 42 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q4 2015 and 39 closed out, a net change of +3 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q4 2015 was Fidelity Investments, an estimated $299M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q4 2015 was VHCP Management, an estimated $114M sold.
Based on aggregated 13F filings for Q4 2015.